Free Trial

Baird Medical Investment (BDMD) Competitors

Baird Medical Investment logo
$2.04 -0.11 (-5.12%)
As of 04:00 PM Eastern

BDMD vs. TELA, APYX, GUTS, NVNO, MDAI, NSPR, SRTS, ZYXI, CTSO, and HYPR

Should you be buying Baird Medical Investment stock or one of its competitors? The main competitors of Baird Medical Investment include TELA Bio (TELA), Apyx Medical (APYX), Fractyl Health (GUTS), enVVeno Medical (NVNO), Spectral AI (MDAI), InspireMD (NSPR), Sensus Healthcare (SRTS), Zynex (ZYXI), Cytosorbents (CTSO), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.

Baird Medical Investment vs. Its Competitors

Baird Medical Investment (NASDAQ:BDMD) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

Baird Medical Investment has a beta of -0.94, indicating that its share price is 194% less volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500.

In the previous week, Baird Medical Investment and Baird Medical Investment both had 5 articles in the media. TELA Bio's average media sentiment score of 0.69 beat Baird Medical Investment's score of 0.37 indicating that TELA Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baird Medical Investment
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
TELA Bio
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Baird Medical Investment has a net margin of 0.00% compared to TELA Bio's net margin of -61.00%. Baird Medical Investment's return on equity of 0.00% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
TELA Bio -61.00%-402.45%-62.73%

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 94.4% of TELA Bio shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by insiders. Comparatively, 4.7% of TELA Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

TELA Bio has a consensus price target of $7.25, suggesting a potential upside of 277.60%. Given TELA Bio's stronger consensus rating and higher possible upside, analysts clearly believe TELA Bio is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
TELA Bio
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Baird Medical Investment has higher earnings, but lower revenue than TELA Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical InvestmentN/AN/AN/AN/AN/A
TELA Bio$69.30M1.10-$37.84M-$1.41-1.36

Summary

TELA Bio beats Baird Medical Investment on 7 of the 11 factors compared between the two stocks.

Get Baird Medical Investment News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BDMD vs. The Competition

MetricBaird Medical InvestmentMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$13.42M$7.00B$5.74B$9.51B
Dividend YieldN/A1.28%4.60%3.99%
P/E RatioN/A25.5128.1120.03
Price / SalesN/A66.31460.63103.88
Price / CashN/A20.6736.5559.01
Price / BookN/A4.758.655.90
Net IncomeN/A$176.14M$3.25B$258.66M
7 Day Performance-34.62%2.92%4.20%2.23%
1 Month Performance-69.28%3.56%10.83%12.77%
1 Year PerformanceN/A7.66%34.67%19.36%

Baird Medical Investment Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDMD
Baird Medical Investment
N/A$2.04
-5.1%
N/AN/A$13.42MN/A0.00N/A
TELA
TELA Bio
2.9425 of 5 stars
$2.03
+1.3%
$7.25
+258.0%
-57.4%$80.11M$69.30M-1.44120
APYX
Apyx Medical
2.0011 of 5 stars
$2.02
+2.3%
N/A+70.5%$76.15M$48.10M-3.66270Gap Up
GUTS
Fractyl Health
2.6197 of 5 stars
$1.53
-2.6%
$11.00
+619.4%
-50.9%$74.45M$90K-0.82102Positive News
NVNO
enVVeno Medical
0.3341 of 5 stars
$4.22
-1.7%
N/A-9.1%$74.28MN/A-3.5930Upcoming Earnings
MDAI
Spectral AI
3.5112 of 5 stars
$2.89
+7.6%
$4.75
+64.6%
+51.4%$73.02M$29.58M-5.3483
NSPR
InspireMD
2.5395 of 5 stars
$2.32
-1.3%
$4.50
+94.0%
-14.4%$70.92M$7.03M-3.0950
SRTS
Sensus Healthcare
1.1291 of 5 stars
$4.30
-0.5%
$11.67
+171.4%
-11.0%$70.53M$41.81M42.9040News Coverage
ZYXI
Zynex
2.1784 of 5 stars
$2.17
+2.8%
$6.00
+176.5%
-74.9%$65.62M$192.35M-9.04770Upcoming Earnings
CTSO
Cytosorbents
1.6677 of 5 stars
$1.03
-1.9%
$5.50
+434.0%
-1.0%$64.49M$35.33M-3.68220Gap Up
HYPR
Hyperfine
1.4355 of 5 stars
$0.79
-1.3%
$1.06
+34.2%
-0.9%$61.49M$11.73M-1.46190News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:BDMD) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners